國立高雄大學圖資館 |

登入

回首頁

Cardiovascular considerations in hematopoietic stem cell transplantation

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Cardiovascular considerations in hematopoietic stem cell transplantationedited by Azin Alizadehasl ... [et al.].
其他作者:	Alizadehasl, Azin.
出版者:	Cham :Springer Nature Switzerland :2024.
面頁冊數:	vi, 291 p. :ill. (chiefly col.), digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Hematopoietic stem cellsTransplantation.
電子資源:	https://doi.org/10.1007/978-3-031-53659-5
ISBN:	9783031536595$q(electronic bk.)

Cardiovascular considerations in hematopoietic stem cell transplantation
Cardiovascular considerations in hematopoietic stem cell transplantation[electronic resource] /edited by Azin Alizadehasl ... [et al.]. - Cham :Springer Nature Switzerland :2024. - vi, 291 p. :ill. (chiefly col.), digital ;24 cm.

HSCT at a glance -- Burden of cardiovascular disease in HSCT -- Risk factors and Mechanisms of Cardiotoxicity in HSCT -- Cardiotoxicity of commonly used drugs in HSCT -- Pre-HSCT cardiovascular evaluation -- HSCT in low EF patients -- Arrhythmias and conduction disorders in HSCT -- Coronary and peripheral arterial disease in HSCT -- Thrombotic disease in HSCT -- Pulmonary hypertension in HSCT -- Pericardial disease in HSCT -- Metabolic syndrome in HSCT -- HSCT in patients with cardiac amyloidosis -- HSCT in patients with autoimmune conditions, sickle cell anaemia and thalassemia -- Cardiotoxicity surveillance and cardioprotective strategies in HSCT.

This book discusses the epidemiology and the known cardiotoxic effects of chemoradiation agents in addition to newer therapies in hematopoietic stem cell transplantation (HSCT) Recent expert consensus statements from cardiology and hematology/oncology societies are reviewed in regard to risk stratification of the patient based on the type of treatments they are undergoing. Finally, gaps in knowledge are identified with proposed avenues of research that allow for more accurate risk assessment, prediction and potential treatment of the HSCT patient in attenuating the risk of developing cardiovascular comorbidities. Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation reveals a picture of effective management of these patients in order to optimize both short- and long-term outcomes of HSCT. It is of considerable interest to all involved or training within this rapidly growing area of cardiology and oncology.

ISBN: 9783031536595$q(electronic bk.)

Standard No.: 10.1007/978-3-031-53659-5doiSubjects--Topical Terms:

201247
Hematopoietic stem cells
--Transplantation.

LC Class. No.: RC271.H45

Dewey Class. No.: 616.02774

Cardiovascular considerations in hematopoietic stem cell transplantation
LDR:02610nmm a22003255a 4500 001 665448
003 DE-He213
005 20240418124939.0
006 m d
007 cr nn 008maaau
008 241219s2024 sz s 0 eng d
020 $a 9783031536595$q(electronic bk.)
020 $a 9783031536588$q(paper)
024 7 $a 10.1007/978-3-031-53659-5 $2 doi
035 $a 978-3-031-53659-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC271.H45
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
072 7 $a MJD $2 thema
082 0 4 $a 616.02774 $2 23
090 $a RC271.H45 $b C267 2024
245 0 0 $a Cardiovascular considerations in hematopoietic stem cell transplantation $h [electronic resource] / $c edited by Azin Alizadehasl ... [et al.].
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2024.
300 $a vi, 291 p. : $b ill. (chiefly col.), digital ; $c 24 cm.
505 0 $a HSCT at a glance -- Burden of cardiovascular disease in HSCT -- Risk factors and Mechanisms of Cardiotoxicity in HSCT -- Cardiotoxicity of commonly used drugs in HSCT -- Pre-HSCT cardiovascular evaluation -- HSCT in low EF patients -- Arrhythmias and conduction disorders in HSCT -- Coronary and peripheral arterial disease in HSCT -- Thrombotic disease in HSCT -- Pulmonary hypertension in HSCT -- Pericardial disease in HSCT -- Metabolic syndrome in HSCT -- HSCT in patients with cardiac amyloidosis -- HSCT in patients with autoimmune conditions, sickle cell anaemia and thalassemia -- Cardiotoxicity surveillance and cardioprotective strategies in HSCT.
520 $a This book discusses the epidemiology and the known cardiotoxic effects of chemoradiation agents in addition to newer therapies in hematopoietic stem cell transplantation (HSCT) Recent expert consensus statements from cardiology and hematology/oncology societies are reviewed in regard to risk stratification of the patient based on the type of treatments they are undergoing. Finally, gaps in knowledge are identified with proposed avenues of research that allow for more accurate risk assessment, prediction and potential treatment of the HSCT patient in attenuating the risk of developing cardiovascular comorbidities. Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation reveals a picture of effective management of these patients in order to optimize both short- and long-term outcomes of HSCT. It is of considerable interest to all involved or training within this rapidly growing area of cardiology and oncology.
650 0 $a Hematopoietic stem cells $x Transplantation. $3 201247
650 0 $a Hematopoietic stem cells $x Transplantation $x Complications $3 978279
650 0 $a Cardiovascular system $x Diseases. $3 276814
650 1 4 $a Cardiology. $3 273804
650 2 4 $a Cancer Genetics and Genomics. $3 918740
700 1 $a Alizadehasl, Azin. $3 684103
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-53659-5
950 $a Medicine (SpringerNature-11650)